Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: amoxicillin attending: chief complaint: tracheobronchomalacia. major surgical or invasive procedure: flexible bronchoscopy with bronchoalveolar lavage, right thoracotomy and tracheoplasty with mesh, left main stem bronchoplasty with mesh, right main stem bronchus/bronchus intermedius bronchoplasty with mesh. history of present illness: ms. is a 52-year-old woman who was found to have severe, diffuse tracheobronchomalacia. her main symptom was dyspnea; but she also had a chronic productive cough. she has also had orthopnea and recurrent respiratory infections. she responded well in terms of her dyspnea to the stent placement therefore is admitted for right thoracotomy, trachaelplasty with mesh placement. past medical history: copd (on 2l home o2) asthma allergic rhinitis atopic dermatitis htn aoregurgitation major depressive disorder with psychotic features history of polysubstance abuse, primarily cocaine anxiety disorder nos with situationally bound panic attacks with agoraphobia polysubstance abuse hx ulcerative colitis menorrhagia gerd osa narcolepsy right humerus fx social history: pt lives with family. no alcohol or ivdu. patient has hx of cocaine abuse. on disability. previous smoker but quit in , smoked ppd from 15 to 25 yo (5pk-yr) and 2 ppd from 25 to 32 yo (14 pk-yr) for total of 19 pk-yr. family history: no family hx of cancer or cad or dvt/pe. physical exam: vs: t 98.1 hr: 87 sr bp: 138/80 96% 2l general: no apparent distress heent: normocephalic, mucus membranes moist neck: supple card: rrr resp: faint bibasilar crackles otherwise clear gi: obese, abdomen soft non-tender/non-distended extr: warm no edema incision: r thoracotomy site clean dry intact, no erythema. ct site clean intact skin: right lower extremity with scattered psorasis areas with some skin breakdown neuro: non-focal pertinent results: wbc-10.7 rbc-3.57* hgb-9.0* hct-28.9 plt ct-302 wbc-14.0* rbc-3.62* hgb-9.4* hct-29.0 plt ct-309 wbc-20.2*# rbc-4.67 hgb-11.7* hct-38.5 plt ct-357 urean-12 creat-0.6 na-144 k-3.8 cl-105 hco3-30 glucose-120* urean-14 creat-0.5 na-142 k-3.8 cl-103 hco3-30 glucose-160* urean-13 creat-0.8 na-137 k-4.9 cl-101 hco3-24 mg-1.9 12:11 pm sputum gram stain (final ): 3+ (5-10 per 1000x field): multiple organisms consistent with oropharyngeal flora. respiratory culture (final ): moderate growth commensal respiratory flora. chest x-ray: the right internal jugular line has been removed. the right upper lobe opacity has improved in the interim and might be consistent with resolution of post-surgical hematoma. chest tube remains and there is no evidence of pneumothorax or substantial effusion, though pleural thickening persists on the right. mild vascular congestion is again seen and there are some streaks of atelectasis at the left base. atelectasis has cleared from the right middle lobe, but consolidation persists in the upper lobe could be asymmetric re-expansion edema, contusion or less likely this early in the postoperative period, aspiration pneumonia. borderline cardiomegaly and mild pulmonary vascular congestion persists and there is subsegmental atelectasis in the left lung, unchanged. right pneumothorax is minimal, at the apex, if any, and right pleural collection is also very small, if any, one basal and one apical pleural tube is still in place. with the chin down, the tip of the endotracheal tube 2.45 cm above the carina is acceptable. right jugular line ends at the junction of brachiocephalic veins. mediastinal drains noted. brief hospital course: mrs. was admtitted on for flexible bronchoscopy with bronchoalveolar lavage, right thoracotomy and tracheoplasty with mesh, left main stem bronchoplasty with mesh, right main stem bronchus/bronchus intermedius bronchoplasty with mesh. she was extubated in the operating room transferred to the sicu for airway monitoring and management. respiratory: aggressive pulmonary toilet with mucolytic nebs and chest pt were administered. she titrated to her home o2 of 2l with oxygen saturations in the high 96%. chest-tube: posterior chest tube was removed on pod2. she was followed by serial chest films which showed atelectasis and stable tiny right apical pneumothorax. cardiac: she remained hemodynamically stable. her afterload medications were restarted. gi: her colitis medications were restarted. her bowel function returned to . nutrition: she tolerated a diabetic diet. renal: on pod 1 she went into acute renal failure with a peak cre 1.8. with hydration her renal function returned to her baseline of 0.8 on pod 2. her diuretics were restarted and she was gentley diuresed. maintained good urine output. endocrine: her blood sugars were 130-150's and covered by insulin sliding scale. her home diabetic medications were restarted once she started a regular/diabetic diet. pain: epidural in place was managed by the acute pain service. it came out on pod4 and she was converted to po pain medications. neuro: history of bipolar, depression for which her home medications were restarted on pod1. disposition: she was seen by physical therapy who deemed her safe for home. she continued to make steady progress and was discharged to home on pod7 medications on admission: mucomyst nebs tid aripiprazole 10 mg po daily benzonatate 200 mg po tid prn couch clobetasol 0.05% ointment 2 weeks per month fluoxetine 60mg po daily fluticasone 50 mcg spray inh fluticasone 220 mcg aerosol - 2 puffs inh advair diskus 500 mcg-50 mcg 1 puff inh lasix 20 mg q8am & 2pm xopenex 0.63 mg/3 ml nebs tid prn sob xopenef hfa 45 mcg inh q4hrs prn sob lisinopril 20 mg po daily mesalamine delayed release 400 - 4 tablets po tid metformin 850 mg po bid montelukast 10 mg po daily omeprazole delayed release 20 mg po daily tiotropium brominde 18 mcg, 1 cap inh qam (10minutes after advair) guaifenisen - 1,200 mg tab, 1 po bid loratidine - 10 mg tablet - 1 po qam discharge medications: 1. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 3. aripiprazole 10 mg tablet sig: one (1) tablet po daily (daily). 4. fluoxetine 20 mg capsule sig: three (3) capsule po daily (daily). 5. mesalamine 400 mg tablet, delayed release (e.c.) sig: four (4) tablet, delayed release (e.c.) po tid (3 times a day). 6. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 7. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po daily (daily). 8. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily). 9. potassium chloride 20 meq tab sust.rel. particle/crystal sig: tab sust.rel. particle/crystals po daily (daily). 10. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day). 11. tiotropium bromide 18 mcg capsule, w/inhalation device sig: one (1) cap inhalation daily (daily). 12. fluticasone-salmeterol 500-50 mcg/dose disk with device sig: one (1) disk with device inhalation (2 times a day). 13. metformin 850 mg tablet sig: one (1) tablet po twice a day. 14. xopenex hfa 45 mcg/actuation hfa aerosol inhaler sig: two (2) inhalation every four (4) hours as needed for shortness of breath or wheezing. 15. oxycodone 5 mg tablet sig: one (1) tablet po every 4-6 hours as needed for pain. disp:*70 tablet(s)* refills:*0* 16. acetaminophen 325 mg tablet sig: 1-2 tablets po q6h (every 6 hours) as needed for pain/headache. 17. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: three (3) ml inhalation every 4-6 hours as needed for wheezing. 18. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po twice a day. 19. calcium carbonate-vitamin d3 500 mg(1,250mg) -400 unit tablet, chewable sig: one (1) tablet, chewable po twice a day. discharge disposition: home with service facility: vna discharge diagnosis: tracheobronchomalacia. discharge condition: mental status:clear and coherent level of consciousness:alert and interactive activity status:ambulatory - independent discharge instructions: call dr. office if experience: -fevers > 101 or chills -increased cough, shortness of breath or sputum production -incision develops drainage -daily weights: keep a log -continue inhalers and nebulizers -continue incentive spirometer 10x every hour while awake -you may shower. no tub bathing or swimming for 6 weeks -take narcotics with stool softners. followup instructions: follow-up with dr. date/time: 11:00 in the building chest disease center i chest x-ray 10:30 in the clinical center radiology department follow-up with your pcp . procedure: other lavage of bronchus and trachea closed [endoscopic] biopsy of bronchus other repair and plastic operations on trachea other repair and plastic operations on bronchus insertion of catheter into spinal canal for infusion of therapeutic or palliative substances systemic to pulmonary artery shunt closure of laceration of lung diagnoses: obstructive sleep apnea (adult)(pediatric) esophageal reflux unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified aortic valve disorders accidental puncture or laceration during a procedure, not elsewhere classified morbid obesity other postprocedural status chronic obstructive asthma, unspecified ulcerative colitis, unspecified other dependence on machines, supplemental oxygen major depressive affective disorder, single episode, severe, specified as with psychotic behavior accidental cut, puncture, perforation or hemorrhage during surgical operation contact dermatitis and other eczema, unspecified cause excessive or frequent menstruation agoraphobia with panic disorder chronic rhinitis cocaine dependence, in remission narcolepsy, without cataplexy 

Answer: The patient is high likely exposed to